Jessen T E, Odum L, Johnsen A H
Department of Clinical Chemistry, Holbaek Central Hospital, Denmark.
Biol Chem Hoppe Seyler. 1994 Aug;375(8):521-6. doi: 10.1515/bchm3.1994.375.8.521.
In vivo binding of human inter-alpha-trypsin inhibitor to hyaluronate was investigated by immunoelectrophoretic techniques. Pathological synovial fluids and follicular fluids both contain high concentrations of soluble hyaluronate. Heavy chain epitopes of inter-alpha-trypsin inhibitor were firmly associated with the hyaluronate in synovial fluid and follicular fluid. The hyaluronate-bound inter-alpha-trypsin inhibitor epitopes did not cross-react immunologically with bikunin. Several hyaluronate-bound inter-alpha-trypsin inhibitor fragments with molecular masses in the range 120,000-30,000 Da were demonstrated by immunoblotting. Heavy chain 1 of inter-alpha-trypsin inhibitor was shown to associate with hyaluronate by amino acid sequence analysis of isolated hyaluronate-bound proteins. These data indicate that in vivo metabolism of inter-alpha-trypsin inhibitor takes place in pathological synovial fluid and in ovarian follicular fluid shortly before ovulation.
采用免疫电泳技术研究了人α-胰蛋白酶抑制剂在体内与透明质酸的结合情况。病理性滑液和卵泡液中均含有高浓度的可溶性透明质酸。α-胰蛋白酶抑制剂的重链表位与滑液和卵泡液中的透明质酸紧密结合。与透明质酸结合的α-胰蛋白酶抑制剂表位在免疫上不与比基尼相关蛋白发生交叉反应。通过免疫印迹法证实了几种分子量在120,000 - 30,000 Da范围内与透明质酸结合的α-胰蛋白酶抑制剂片段。通过对分离出的与透明质酸结合的蛋白质进行氨基酸序列分析,表明α-胰蛋白酶抑制剂重链1与透明质酸相关。这些数据表明,α-胰蛋白酶抑制剂的体内代谢发生在排卵前不久的病理性滑液和卵巢卵泡液中。